Overview
Lobbying Costs
37,500€
Financial year: Jan 2019 - Dec 2019
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
CRISPR Therapeutics
EU Transparency Register
288504936101-19 First registered on 03 Oct 2019
Goals / Remit
At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases
Main EU files targeted
Crispr Therapeutics monitors policy discussions relevant to the biopharmaceutical sector in general and for the research and development of gene-based medicines in particular. We are interested in interacting with European institutions and stakeholders on all topical issues relating to healthcare policy, access to the market, research and innovation, and competitiveness.
Address
Head Office
Baarerstrasse 14
Zug CH
SWITZERLAND -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 20 May 2024
Name Start date End Date Mr John MARTIN 16 Oct 2019 16 Oct 2020 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2019 - Dec 2019
Lobbying costs for closed financial year
37,500€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
Meetings
Meetings
None declared